High TBC1D10B expression was associated with female patients (Fig. 4B), non-overweight patients (body mass index [BMI] ≤ 25; Fig. 4C), alpha-fetoprotein elevation (AFP > 400; Fig. 4J), tumor bearing (Fig. 4K), residual tumor (R1; Fig. 4L), high histologic grade (grade 3/4; Fig. 4E), and more severe T stages (T3 and T4; Fig. 4F) and pathologic stages (stages III and IV; Fig. 4I). The gene discussed is TBC1D10B; the disease is neoplasm.